Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications.
cisplatin
coordination compounds
drug delivery systems
nucleoside analogues
platinum drugs
red blood cells
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
22 Sep 2023
22 Sep 2023
Historique:
received:
05
09
2023
revised:
19
09
2023
accepted:
20
09
2023
medline:
23
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
The therapeutic advantages of some platinum complexes as major anticancer chemotherapeutic agents and of nucleoside analogue-based compounds as essential antiviral/antitumor drugs are widely recognized. Red blood cells (RBCs) offer a potential new strategy for the targeted release of therapeutic agents due to their biocompatibility, which can protect loaded drugs from inactivation in the blood, thus improving biodistribution. In this study, we evaluated the feasibility of loading model nucleobase-containing Pt(II) complexes into human RBCs that were highly stabilized by four
Identifiants
pubmed: 37836603
pii: molecules28196760
doi: 10.3390/molecules28196760
pmc: PMC10574024
pii:
doi:
Substances chimiques
Organoplatinum Compounds
0
Platinum
49DFR088MY
Antineoplastic Agents
0
Antiviral Agents
0
Guanosine
12133JR80S
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian MInistry of University (MIUR) PON "BIO-D" project "Sviluppo di Biomarcatori Diagnostici per la medicina di precisione e la terapia personalizzata"
ID : ARS01_00876
Références
Chem Sci. 2020 Nov 12;11(48):12888-12917
pubmed: 34123239
J Inorg Biochem. 2005 Mar;99(3):795-804
pubmed: 15708801
Biomacromolecules. 2021 Feb 8;22(2):732-742
pubmed: 33331770
Transfus Med Rev. 2012 Jul;26(3):209-223.e3
pubmed: 22119493
Expert Opin Drug Deliv. 2010 Apr;7(4):403-27
pubmed: 20192900
Magn Reson Med. 1998 Jul;40(1):133-42
pubmed: 9660563
J Control Release. 2004 Feb 20;95(1):27-49
pubmed: 15013230
J Am Chem Soc. 2014 Jan 15;136(2):638-41
pubmed: 24359116
J Control Release. 2007 Apr 2;118(2):145-60
pubmed: 17270305
Cancers (Basel). 2020 Jan 18;12(1):
pubmed: 31963766
J Inorg Biochem. 2014 Jan;130:28-31
pubmed: 24148759
Chem Sci. 2021 Oct 6;12(43):14353-14362
pubmed: 34880985
Angew Chem Int Ed Engl. 2022 Jun 20;61(25):e202203838
pubmed: 35352863
Theranostics. 2022 Feb 7;12(5):2115-2132
pubmed: 35265202
Gene Ther. 2002 Jun;9(11):749-51
pubmed: 12032702
Theranostics. 2015 Apr 27;5(8):863-81
pubmed: 26000058
Anal Chem. 2015 Jan 6;87(1):706-15
pubmed: 25485990
Transfus Med Rev. 2017 Jan;31(1):26-35
pubmed: 27707522
Biotechnol Appl Biochem. 1992 Jun;15(3):267-77
pubmed: 1388819
Folia Haematol Int Mag Klin Morphol Blutforsch. 1980;107(3):434-53
pubmed: 6159281
Pharmaceutics. 2023 Mar 14;15(3):
pubmed: 36986802
Molecules. 2022 Oct 01;27(19):
pubmed: 36235023
Molecules. 2019 Jun 15;24(12):
pubmed: 31208065
Chem Rev. 2016 Mar 9;116(5):3436-86
pubmed: 26865551
3 Biotech. 2019 Jul;9(7):279
pubmed: 31245243
J Inorg Biochem. 2022 Jan;226:111660
pubmed: 34801970
Cancer Chemother Pharmacol. 2016 Jun;77(6):1103-24
pubmed: 26886018
Dalton Trans. 2010 Sep 21;39(35):8113-27
pubmed: 20593091
ACS Nano. 2015 Aug 25;9(8):8239-48
pubmed: 26234938
Pharmaceutics. 2020 Mar 18;12(3):
pubmed: 32197542
Biomater Sci. 2023 May 2;11(9):3252-3268
pubmed: 36939172
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):73-87
pubmed: 27189231
J Inorg Biochem. 2016 Oct;163:143-146
pubmed: 27421694
Biochem Biophys Res Commun. 1992 Jan 31;182(2):760-6
pubmed: 1734882
J Biomed Nanotechnol. 2014 Sep;10(9):1732-50
pubmed: 25992439
Contrast Media Mol Imaging. 2014 May-Jun;9(3):229-36
pubmed: 24700750
Drug Discov Today. 2018 Mar;23(3):503-518
pubmed: 29339107
J Cancer Sci Ther. 2019;11(4):
pubmed: 32148661
J Nanobiotechnology. 2023 Aug 22;21(1):288
pubmed: 37608283
J Med Chem. 1984 Apr;27(4):444-9
pubmed: 6538600
ACS Nano. 2023 Mar 28;17(6):5187-5210
pubmed: 36896898
Angew Chem Int Ed Engl. 2019 Jan 21;58(4):968-994
pubmed: 29999221
J Leukoc Biol. 1997 Jul;62(1):133-7
pubmed: 9226004
Angew Chem Int Ed Engl. 2008;47(3):507-10
pubmed: 18058887
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5):
pubmed: 28116852
J Inorg Biochem. 2015 Dec;153:279-283
pubmed: 26050880
Int J Mol Sci. 2023 Jun 07;24(12):
pubmed: 37372996
ChemMedChem. 2022 Dec 5;17(23):e202200482
pubmed: 36178204
Int J Pharm. 2017 Jan 30;517(1-2):175-184
pubmed: 27939571
Pharmaceutics. 2023 Jan 21;15(2):
pubmed: 36839691
Chem Rev. 2014 Apr 23;114(8):4540-63
pubmed: 24456146
Adv Exp Med Biol. 1992;326:239-45
pubmed: 1295313
Nanomedicine (Lond). 2020 Apr;15(8):739-753
pubmed: 32207374
BioDrugs. 2020 Jun;34(3):265-272
pubmed: 32198632
Nanomedicine (Lond). 2018 Apr 1;13(7):675-687
pubmed: 29488423